TRAWS PHARMA INC (TRAW)

US68232V8019 - Common Stock

0.362  +0.01 (+2.26%)

After market: 0.3502 -0.01 (-3.26%)

News Image
22 days ago - InvestorPlace

TRAW Stock Earnings: Traws Pharma Reported Results for Q2 2024

Traws Pharma just reported results for the second quarter of 2024.

News Image
22 days ago - BusinessInsider

TRAW Stock Earnings: Traws Pharma Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Traws Pharma (NASDAQ:TRAW) just reported results for the second quarter of 2024...

News Image
23 days ago - Traws Pharma, Inc.

Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights

Merger with Trawsfynydd Therapeutics, Inc (“Trawsfynydd”) and concurrent private placement of $14 million (cash runway to support planned operations...

News Image
23 days ago - Traws Pharma, Inc.

Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET

NEWTOWN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical company developing...

News Image
4 months ago - Traws Pharma, Inc.

Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate

Differentiated resistance profile positions Traws’ program as a potential class leader

News Image
4 months ago - Traws Pharma, Inc.

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update...